“…1 H NMR (400 MHz, MeOD) d 5.23 (t, J ¼ 9.2 Hz, 1H, H-3), 4.96-4.92 (m, 1H, H-4)*, 4.86 (dd, J ¼ 9.3, 7.4 Hz, 1H, H-2), 4.60 (d, J ¼ 7.4 Hz, 1H, H-1), 4.08 (dd, J ¼ 11.7, 5.4 Hz, 1H, H-5 eq ), 3.88 (dt, J ¼ 9.8, 5.7 Hz, 1H, O-CH 2 -), 3.61 (dt, J ¼ 9.8, 5.7 Hz, 1H O-CH 2 -), 3.47 (dd, J ¼ 11.7, 9.8 Hz, 1H, H-5 ax ), 2.95 (t, J ¼ 6.8 Hz, 2H, CH 2 -N), 2.06 (s, 3H, Ac), 2.03 (s, 3H, Ac), 2.02 (s, 3H, Ac), (m, 4H, -CH 2 -CH 2 -). 13 4-(6,8-Diuoro-7-hydroxycoumarin-3-carboxamido)butyl 2,3,4-tri-O-acetyl-b-D-xylopyranoside (19). 18 (41.4 mg, 0.121 mmol) was subjected to procedure C to yield 19 as a yellow amorphous solid (41.5 mg, 0.0698 mmol, 58%) [a] 25 D 35.2 (c 0.39, MeCN).…”